<DOC>
	<DOCNO>NCT00770692</DOCNO>
	<brief_summary>The purpose study evaluate long-term safety eszopiclone ( 2 , 3 mg ) non-elderly patient insomnia eszopiclone ( 1 , 2 mg ) elderly patient insomnia .</brief_summary>
	<brief_title>A Phase III Study Eszopiclone Patients With Insomnia ( Study SEP 190-150 )</brief_title>
	<detailed_description>This multicenter , randomize , double-blinded study evaluate long-term safety SEP-190 ( 2 , 3 mg ) non-elderly patient insomnia SEP-190 ( 1 , 2 mg ) elderly patient insomnia .</detailed_description>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Eszopiclone</mesh_term>
	<criteria>Inclusion criterion : 1 . Participants submit write informed consent study entry . 2 . Participants age great equal 20 less 85 year age time obtain informed consent . 3 . Participants diagnose primary insomnia base Diagnostic Statistical Manual Mental Disorders , text revision ( DSMIVTR ) Japanese version diagnose insomnia associate psychiatric physical disorder ( ) . 4 . Participants follow condition persistent 4 week longer start observation period : Total sleep time le equal 390 minute equal 3 day week Time fall asleep take equal 30 minute equal 3 day week 5 . Participants data least 2 consecutive day diary entry observation period confirm meet follow two criterion : Total sleep time le equal 390 minute equal 3 day week Time fall asleep take equal 30 minute equal 3 day week Exclusion criterion : 1 . Participants present history follow disease specify MiniInternational Neuropsychiatric Interview ( M.I.N.I . ) Japanese version 5.0 : Risk suicide ( Mild ) manic episode Posttraumatic stress disorder ( PTSD ) Alcohol dependence abuse Drug ( nonalcohol ) dependence abuse Anorexia nervosa Bulimia nervosa Antisocial personality disorder 2 . Participants pharmacologically induce insomnia ( druginduced insomnia ) . 3 . Participants comorbid primary sleep disorder ( circadian rhythm disorder , restless legs movement syndrome , periodic limb movement disorder , sleep apnea syndrome , etc . ) primary insomnia . 4 . Participants symptoms significantly disturb sleep pain , fever , diarrhea , frequent micturation , cough . 5 . Participants unstable primary disease present insomnia 4 week start observation period . 6 . Participants organic mental disorder .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>insomnia</keyword>
	<keyword>primary insomnia</keyword>
	<keyword>insomnia associate psychiatric physical disorder ( )</keyword>
</DOC>